85 related articles for article (PubMed ID: 3356004)
1. Effect of recombinant human interferon-alpha A/D on in vivo murine tumor cell growth.
Uno K; Shimizu S; Inaba K; Kitaura M; Nakahira K; Kato T; Yamaguchi Y; Muramatsu S
Cancer Res; 1988 May; 48(9):2366-71. PubMed ID: 3356004
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect effects of interferon on in vivo murine tumor cell growth.
Uno K; Shimizu S; Ido M; Naito K; Inaba K; Oku T; Kishida T; Muramatsu S
Cancer Res; 1985 Mar; 45(3):1320-7. PubMed ID: 2578878
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant alpha-interferon-gelatin conjugate on in vivo murine tumor cell growth.
Tabata Y; Uno K; Yamaoka T; Ikada Y; Muramatsu S
Cancer Res; 1991 Oct; 51(20):5532-8. PubMed ID: 1833052
[TBL] [Abstract][Full Text] [Related]
4. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
Boraschi D; Niederhuber JE
J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
[TBL] [Abstract][Full Text] [Related]
8. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
Segawa K; Ueno Y; Kataoka T
Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
11. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
[TBL] [Abstract][Full Text] [Related]
12. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
[TBL] [Abstract][Full Text] [Related]
13. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
15. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of antiproliferative and host immunity-associated activity of mouse interferon in murine tumor therapy.
Kataoka T; Oh-hashi F; Sakurai Y; Usuki K; Ida N
Cancer Res; 1984 Dec; 44(12 Pt 1):5661-5. PubMed ID: 6498826
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
19. Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
Blasi E; Herberman RB; Varesio L
J Immunol; 1984 Jun; 132(6):3226-8. PubMed ID: 6725951
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.
Ling PD; Warren MK; Vogel SN
J Immunol; 1985 Sep; 135(3):1857-63. PubMed ID: 3926890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
